{"cmr":"ca-cm-kg/TSX/APLI","node":"ca-cm-kg","as_of":"2026-11-06","version":1,"identity":{"name":{"value":"Appili Therapeutics Inc.","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"ticker":{"value":"APLI","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"exchange":{"value":"TSX","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"security_type":{"value":"Corporate","source_url":"https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)","read_by":"TMX listed-companies workbook (exchange list, monthly; data month named in the source column)","state":"sourced"},"isin":{"value":"CA03783R1073","source_url":"https://www.investing.com/equities/appili-therapeutics-inc","read_by":"Tavily search + regex extraction from page text","state":"confirmed","second_source_url":"https://ca.marketscreener.com/quote/stock/APPILI-THERAPEUTICS-INC-60546364","second_read_by":"Tavily second read (different domain)"},"lei":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"ISIN not in the GLEIF ISIN-to-LEI mapping file"},"sector":{"value":"Life Sciences","source_url":"https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)","read_by":"TMX listed-companies workbook (exchange list, monthly; data month named in the source column)","state":"sourced"},"jurisdiction":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"none found"},"transfer_agent":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"none found"},"auditor":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"none found"},"newswire":{"value":"GlobeNewswire","source_url":"https://www.globenewswire.com/news-release/2026/02/18/3240082/0/en/Appili-Therapeutics-Announces-Closing-of-Second-Tranche-of-Non-Brokered-Private-Placement.html","read_by":"Tavily search restricted to wire domains (release hits)","state":"confirmed","second_source_url":"Width 1 events: 2 of 2 releases on GlobeNewswire","second_read_by":"Width 1 12-month event set (independent observation)"},"hq_city":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"TMX workbook gives province/region only"},"hq_region":{"value":"NS","source_url":"https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)","read_by":"TMX listed-companies workbook (exchange list, monthly; data month named in the source column)","state":"sourced"},"tier":{"value":"n/a (single-tier market)","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"sedar_profile":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"no SEDAR+ profile matched name"},"sedi_link":{"value":"https://www.sedi.ca/sedi/SVTIIBIselectIssuer?locale=en_CA","source_url":null,"read_by":"constructed (SEDI insider-information-by-issuer search entry; no issuer number known) — UNVERIFIED: HTTP 403 on fetch","state":"unverified"}},"aliases":[],"events_url":"https://mcp.ca-cm-kg.ai/events/TSX/APLI","event_count":4,"gaps":[{"field":"LEI","reason":"ISIN not in the GLEIF ISIN-to-LEI mapping file"},{"field":"Incorporation jurisdiction","reason":"none found"},{"field":"SEDAR+ profile link","reason":"no SEDAR+ profile matched name"},{"field":"SEDI link","reason":"unverified: sedi.ca returns HTTP 403 to automated clients"},{"field":"Transfer agent","reason":"none found"},{"field":"Auditor","reason":"none found"},{"field":"HQ city","reason":"TMX workbook gives province/region only"}],"halt":{"value":false,"source_url":"https://iiroc.mediaroom.com/index.php?s=2429&l=100","read_by":"CIRO Halts/Resumptions bulletins (iiroc.mediaroom.com)","read_at":"2026-11-08T09:32:00Z","state":"sourced"},"schema":"ECO-10060 v1.2 §7.1 · record schema v0.2 (unratified)","instrument_class":{"value":"Corporate Issuer","from":"TSX Listing Fee Schedule, B. Definitions (Corporate Issuer: issuer, including a special purpose acquisition corporation, other than a Closed-end Fund, Exchange Traded Product or Structured Product); D. Listing Fees Applicable to Corporate Issuers","source_url":"https://www.tsx.com/en/resource/1644","source_date":"Effective January 1, 2018","read_at":"2026-10-31T19:33:54Z","state":"sourced","basis":"rulebook","group":"tsx|Corporate"},"signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PRFdYe8pMr1-xwr_r51n4JFUNOPRaNJiLhtvn1Ml7lAPxItq74UPcgfODjklGOUnOLGxKQF47JATP8ydlJ-dBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}